Literature DB >> 17088223

Outpatient treatment engagement and abstinence rates following inpatient opioid detoxification.

John W Davison1, Marie L Sweeney, Kristen R Bush, Tania M Davis Correale, Donald A Calsyn, Joseph P Reoux, Kevin L Sloan, Daniel R Kivlahan.   

Abstract

Many patients with chronic opioid dependence are referred to drug-free outpatient treatment following inpatient detoxification even though successful outpatient treatment engagement and abstinence from opioids occur only in a minority of cases. This retrospective cohort analysis of medical records documents the post-discharge outcome in a treatment setting that maximizes the support during transition to abstinence-oriented outpatient care, with comprehensive social, medical and mental health services, including the availability of naltrexone. Participants were male veterans (N = 112) admitted at an urban VA medical center. Most patients (78%) successfully completed acute detoxification, 49% initiated naltrexone, and 76% accepted a VA aftercare plan. At 90-day follow-up, only 22% remained in aftercare, and < 3% had toxicology-verified abstinence from opioids. At one-year follow-up, 1 out of 5 had been readmitted for detoxification and 4.5% had died. Most patients successfully detoxified from opioids, but very few remained engaged and stabilized in abstinence-oriented outpatient treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17088223     DOI: 10.1300/J069v25n04_03

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  7 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 2.  Pharmacological strategies for detoxification.

Authors:  Alison M Diaper; Fergus D Law; Jan K Melichar
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

3.  Randomized controlled trial of enhanced telephone monitoring with detoxification patients: 3- and 6-month outcomes.

Authors:  Christine Timko; Maureen Below; Lisa Vittorio; Emmeline Taylor; Grace Chang; Steven Lash; Fe Erlita D Festin; Deborah Brief
Journal:  J Subst Abuse Treat       Date:  2019-01-04

4.  Challenges in the scale-up of opioid substitution treatment in India.

Authors:  Atul Ambekar; Pratima Murthy; Debasish Basu; G Prasad Rao; Ashwin Mohan
Journal:  Indian J Psychiatry       Date:  2017 Jan-Mar       Impact factor: 1.759

5.  Factors associated with readmission to alcohol and opioid detoxification in the Alaska Interior.

Authors:  Ursula Running Bear; Jessica D Hanson; Carolyn Noonan; Clemma Muller; Jodi Trojan; Spero M Manson
Journal:  Am J Addict       Date:  2022-04-17

Review 6.  Pharmacologic treatments for opioid dependence: detoxification and maintenance options.

Authors:  Herbert D Kleber
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

7.  The Key to Individualized Addiction Treatment is Comprehensive Assessment and Monitoring of Symptoms and Behavioral Change.

Authors:  Thomas F Hilton; Paul A Pilkonis
Journal:  Behav Sci (Basel)       Date:  2015-10-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.